Bringing Genetoo to Market
Secured patent licensing and Space Act Agreement Collaboration with NASA; assembled operational and advisory teams.
Developed initial prototype; completed preliminary testing according to FDA guidance, assessed bacterial adhesion and biocompatibility.
PHASE 2 (CURRENT PHASE)
Secure fundings; complete testing, and submit Master File to the FDA to support commercialization; establish partnerships with laser facilities to address industrial upscaling.
Establish strategic partnerships engaging both medical device manufacturers and health insurance providers to bring Genetoo technology to market and to patients.